Adamas Operations Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ADAMAS OPERATIONS, and when can generic versions of ADAMAS OPERATIONS drugs launch?
ADAMAS OPERATIONS has two approved drugs.
There are twenty-nine US patents protecting ADAMAS OPERATIONS drugs.
There are forty-five patent family members on ADAMAS OPERATIONS drugs in eleven countries.
Summary for Adamas Operations
International Patents: | 45 |
US Patents: | 29 |
Tradenames: | 2 |
Ingredients: | 1 |
NDAs: | 2 |
Drugs and US Patents for Adamas Operations
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Adamas Operations | OSMOLEX ER | amantadine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 209410-001 | Feb 16, 2018 | RX | Yes | No | 8,895,616 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Adamas Operations | OSMOLEX ER | amantadine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 209410-002 | Feb 16, 2018 | RX | Yes | No | 10,512,617 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Adamas Operations | OSMOLEX ER | amantadine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 209410-001 | Feb 16, 2018 | RX | Yes | No | 8,796,337 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Adamas Operations | OSMOLEX ER | amantadine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 209410-003 | Feb 16, 2018 | DISCN | Yes | No | 8,895,618 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Adamas Operations | OSMOLEX ER | amantadine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 209410-002 | Feb 16, 2018 | RX | Yes | No | 8,987,333 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Adamas Operations | OSMOLEX ER | amantadine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 209410-003 | Feb 16, 2018 | DISCN | Yes | No | 8,389,578 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Adamas Operations | OSMOLEX ER | amantadine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 209410-001 | Feb 16, 2018 | RX | Yes | No | 8,889,740 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Adamas Operations
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Adamas Operations | OSMOLEX ER | amantadine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 209410-001 | Feb 16, 2018 | RE39069 | ⤷ Try a Trial |
Adamas Operations | OSMOLEX ER | amantadine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 209410-002 | Feb 16, 2018 | RE39069 | ⤷ Try a Trial |
Adamas Operations | OSMOLEX ER | amantadine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 209410-003 | Feb 16, 2018 | RE39069 | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Adamas Operations Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Canada | 2589479 | ⤷ Try a Trial |
Canada | 2588296 | ⤷ Try a Trial |
World Intellectual Property Organization (WIPO) | 2006089494 | ⤷ Try a Trial |
China | 111372578 | ⤷ Try a Trial |
Mexico | 365650 | ⤷ Try a Trial |
European Patent Office | 2623099 | ⤷ Try a Trial |
Brazil | 112020003375 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.